<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9E90A72A-4A7B-4D2D-854B-4DE60094219A"><gtr:id>9E90A72A-4A7B-4D2D-854B-4DE60094219A</gtr:id><gtr:name>St James's University Hospital (Jimmy's)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4AAE76DE-5807-40EF-B3FE-824A330ECEF3"><gtr:id>4AAE76DE-5807-40EF-B3FE-824A330ECEF3</gtr:id><gtr:name>South Tees Hospitals NHS Foundtn Trust</gtr:name><gtr:address><gtr:line1>James Cook Hospital</gtr:line1><gtr:line2>Marton Road</gtr:line2><gtr:postCode>TS4 3BW</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/02E75A29-90CA-42CE-982A-B16FA4FC5905"><gtr:id>02E75A29-90CA-42CE-982A-B16FA4FC5905</gtr:id><gtr:name>Frimley Health NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0FD01CC2-BEC0-446C-B6B3-492C7AEEBAD6"><gtr:id>0FD01CC2-BEC0-446C-B6B3-492C7AEEBAD6</gtr:id><gtr:name>Southampton General Hospital</gtr:name><gtr:address><gtr:line1>Southampton General Hospital</gtr:line1><gtr:line2>Tremona Road</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E6ADDEA8-D0AE-4CA2-8C9F-42AAE8E6ECCC"><gtr:id>E6ADDEA8-D0AE-4CA2-8C9F-42AAE8E6ECCC</gtr:id><gtr:name>East Lancashire Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Midtherm Estate</gtr:line1><gtr:line2>New Road</gtr:line2><gtr:line3>Netherton</gtr:line3><gtr:postCode>DY2 8SY</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5FC83AA7-853D-47DA-813E-292E214EA8E5"><gtr:id>5FC83AA7-853D-47DA-813E-292E214EA8E5</gtr:id><gtr:name>University Hospital Lewisham</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B12D183A-BE68-45C2-A877-D14458972CE7"><gtr:id>B12D183A-BE68-45C2-A877-D14458972CE7</gtr:id><gtr:name>Shrewsbury and Telford Hospital NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D3D8A940-2BB9-4960-A5F6-1F54554C34FA"><gtr:id>D3D8A940-2BB9-4960-A5F6-1F54554C34FA</gtr:id><gtr:name>Portsmouth Hospitals NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BDFA256A-9A09-4221-BDF8-D0543F3EF453"><gtr:id>BDFA256A-9A09-4221-BDF8-D0543F3EF453</gtr:id><gtr:name>Gilead Sciences, Inc.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1BD4A556-B16E-4335-AE9D-9DD36A9FEF33"><gtr:id>1BD4A556-B16E-4335-AE9D-9DD36A9FEF33</gtr:id><gtr:name>University Hospitals of Morecambe Bay NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3CF64D0E-54D2-42CF-AF7D-E2176AB6CCAD"><gtr:id>3CF64D0E-54D2-42CF-AF7D-E2176AB6CCAD</gtr:id><gtr:name>Hull Royal Infirmary</gtr:name><gtr:address><gtr:line1>Anlaby Road</gtr:line1><gtr:line4>Hull</gtr:line4><gtr:line5>North Humberside</gtr:line5><gtr:postCode>HU3 2JZ</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DD68C71-6946-40A2-B245-AF543E956C1E"><gtr:id>3DD68C71-6946-40A2-B245-AF543E956C1E</gtr:id><gtr:name>Chelsea and Westminster Hospital NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/129081D6-64EA-49BF-A8EE-69D1925F6B8B"><gtr:id>129081D6-64EA-49BF-A8EE-69D1925F6B8B</gtr:id><gtr:name>Blackpool Victoria Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1AF5F6BE-7C00-4B82-9E89-38545CE86CB4"><gtr:id>1AF5F6BE-7C00-4B82-9E89-38545CE86CB4</gtr:id><gtr:name>Pennine Acute Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Bury General Hospital</gtr:line1><gtr:line2>Walmersley Road</gtr:line2><gtr:postCode>BL9 6PG</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D3B5235B-CC4A-4B38-8E39-5179BAFB4DE7"><gtr:id>D3B5235B-CC4A-4B38-8E39-5179BAFB4DE7</gtr:id><gtr:name>Birmingham Heartlands Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0DC7C86D-4D88-4C0E-BD4A-C6E1ECEAE3B5"><gtr:id>0DC7C86D-4D88-4C0E-BD4A-C6E1ECEAE3B5</gtr:id><gtr:name>Buckinghamshire Healthcare NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CD9804F2-50A4-406E-AC16-DA4D12D481EA"><gtr:id>CD9804F2-50A4-406E-AC16-DA4D12D481EA</gtr:id><gtr:name>Singleton Hospital</gtr:name><gtr:address><gtr:line1>Singleton Hospital</gtr:line1><gtr:postCode>SA2 8QA</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5434604E-D9AC-4B94-A674-60D8F11B91A3"><gtr:id>5434604E-D9AC-4B94-A674-60D8F11B91A3</gtr:id><gtr:name>Bradford Royal Infirmary</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7140F2B7-4F80-40FD-9EF7-C5B2B43D5C29"><gtr:id>7140F2B7-4F80-40FD-9EF7-C5B2B43D5C29</gtr:id><gtr:name>Royal Preston Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CC884DBE-E63D-416D-8328-48CB16276834"><gtr:id>CC884DBE-E63D-416D-8328-48CB16276834</gtr:id><gtr:name>Manchester Royal Infirmary</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8FF77491-6D8F-46B3-A501-502C02F1142F"><gtr:id>8FF77491-6D8F-46B3-A501-502C02F1142F</gtr:id><gtr:name>Bristol Royal Infirmary</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DBCEE86-6873-4669-9B35-B4EEEAE13F52"><gtr:id>3DBCEE86-6873-4669-9B35-B4EEEAE13F52</gtr:id><gtr:name>Royal Liverpool University NHS Hospitals</gtr:name><gtr:address><gtr:line1>Prescot Street</gtr:line1><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L7 8XP</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46DB0EB7-3DE7-4E45-BFC0-2E7255E49A4B"><gtr:id>46DB0EB7-3DE7-4E45-BFC0-2E7255E49A4B</gtr:id><gtr:name>Bristol-Myers Squibb</gtr:name><gtr:address><gtr:line1>Bristol-Myers Squibb</gtr:line1><gtr:line2>311 Pennington Rocky Hill Road</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2CFA3CCE-D7B5-4E91-8299-47E773A16C97"><gtr:id>2CFA3CCE-D7B5-4E91-8299-47E773A16C97</gtr:id><gtr:name>Abbvie</gtr:name><gtr:address><gtr:line1>1 North Waukegan Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/14EB02E5-BEC0-4CCC-8EF4-CCECDD113817"><gtr:id>14EB02E5-BEC0-4CCC-8EF4-CCECDD113817</gtr:id><gtr:name>St George's NHS Trust, London</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/591A3A9A-B9DC-4D31-8660-2E747AAEDFAE"><gtr:id>591A3A9A-B9DC-4D31-8660-2E747AAEDFAE</gtr:id><gtr:name>Royal Sussex County Hospital</gtr:name><gtr:address><gtr:line1>Royal Sussex County Hospital</gtr:line1><gtr:line2>Eastern Road</gtr:line2><gtr:postCode>BN2  5BE</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CFA47428-36B9-43F1-A098-71C95C3D7474"><gtr:id>CFA47428-36B9-43F1-A098-71C95C3D7474</gtr:id><gtr:name>STOP-HCV</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9E90A72A-4A7B-4D2D-854B-4DE60094219A"><gtr:id>9E90A72A-4A7B-4D2D-854B-4DE60094219A</gtr:id><gtr:name>St James's University Hospital (Jimmy's)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4AAE76DE-5807-40EF-B3FE-824A330ECEF3"><gtr:id>4AAE76DE-5807-40EF-B3FE-824A330ECEF3</gtr:id><gtr:name>South Tees Hospitals NHS Foundtn Trust</gtr:name><gtr:address><gtr:line1>James Cook Hospital</gtr:line1><gtr:line2>Marton Road</gtr:line2><gtr:postCode>TS4 3BW</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02E75A29-90CA-42CE-982A-B16FA4FC5905"><gtr:id>02E75A29-90CA-42CE-982A-B16FA4FC5905</gtr:id><gtr:name>Frimley Health NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0FD01CC2-BEC0-446C-B6B3-492C7AEEBAD6"><gtr:id>0FD01CC2-BEC0-446C-B6B3-492C7AEEBAD6</gtr:id><gtr:name>Southampton General Hospital</gtr:name><gtr:address><gtr:line1>Southampton General Hospital</gtr:line1><gtr:line2>Tremona Road</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E6ADDEA8-D0AE-4CA2-8C9F-42AAE8E6ECCC"><gtr:id>E6ADDEA8-D0AE-4CA2-8C9F-42AAE8E6ECCC</gtr:id><gtr:name>East Lancashire Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Midtherm Estate</gtr:line1><gtr:line2>New Road</gtr:line2><gtr:line3>Netherton</gtr:line3><gtr:postCode>DY2 8SY</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5FC83AA7-853D-47DA-813E-292E214EA8E5"><gtr:id>5FC83AA7-853D-47DA-813E-292E214EA8E5</gtr:id><gtr:name>University Hospital Lewisham</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B12D183A-BE68-45C2-A877-D14458972CE7"><gtr:id>B12D183A-BE68-45C2-A877-D14458972CE7</gtr:id><gtr:name>Shrewsbury and Telford Hospital NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D3D8A940-2BB9-4960-A5F6-1F54554C34FA"><gtr:id>D3D8A940-2BB9-4960-A5F6-1F54554C34FA</gtr:id><gtr:name>Portsmouth Hospitals NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BDFA256A-9A09-4221-BDF8-D0543F3EF453"><gtr:id>BDFA256A-9A09-4221-BDF8-D0543F3EF453</gtr:id><gtr:name>Gilead Sciences, Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1BD4A556-B16E-4335-AE9D-9DD36A9FEF33"><gtr:id>1BD4A556-B16E-4335-AE9D-9DD36A9FEF33</gtr:id><gtr:name>University Hospitals of Morecambe Bay NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3CF64D0E-54D2-42CF-AF7D-E2176AB6CCAD"><gtr:id>3CF64D0E-54D2-42CF-AF7D-E2176AB6CCAD</gtr:id><gtr:name>Hull Royal Infirmary</gtr:name><gtr:address><gtr:line1>Anlaby Road</gtr:line1><gtr:line4>Hull</gtr:line4><gtr:line5>North Humberside</gtr:line5><gtr:postCode>HU3 2JZ</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DD68C71-6946-40A2-B245-AF543E956C1E"><gtr:id>3DD68C71-6946-40A2-B245-AF543E956C1E</gtr:id><gtr:name>Chelsea and Westminster Hospital NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/129081D6-64EA-49BF-A8EE-69D1925F6B8B"><gtr:id>129081D6-64EA-49BF-A8EE-69D1925F6B8B</gtr:id><gtr:name>Blackpool Victoria Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1AF5F6BE-7C00-4B82-9E89-38545CE86CB4"><gtr:id>1AF5F6BE-7C00-4B82-9E89-38545CE86CB4</gtr:id><gtr:name>Pennine Acute Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Bury General Hospital</gtr:line1><gtr:line2>Walmersley Road</gtr:line2><gtr:postCode>BL9 6PG</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D3B5235B-CC4A-4B38-8E39-5179BAFB4DE7"><gtr:id>D3B5235B-CC4A-4B38-8E39-5179BAFB4DE7</gtr:id><gtr:name>Birmingham Heartlands Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0DC7C86D-4D88-4C0E-BD4A-C6E1ECEAE3B5"><gtr:id>0DC7C86D-4D88-4C0E-BD4A-C6E1ECEAE3B5</gtr:id><gtr:name>Buckinghamshire Healthcare NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CD9804F2-50A4-406E-AC16-DA4D12D481EA"><gtr:id>CD9804F2-50A4-406E-AC16-DA4D12D481EA</gtr:id><gtr:name>Singleton Hospital</gtr:name><gtr:address><gtr:line1>Singleton Hospital</gtr:line1><gtr:postCode>SA2 8QA</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5434604E-D9AC-4B94-A674-60D8F11B91A3"><gtr:id>5434604E-D9AC-4B94-A674-60D8F11B91A3</gtr:id><gtr:name>Bradford Royal Infirmary</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7140F2B7-4F80-40FD-9EF7-C5B2B43D5C29"><gtr:id>7140F2B7-4F80-40FD-9EF7-C5B2B43D5C29</gtr:id><gtr:name>Royal Preston Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CC884DBE-E63D-416D-8328-48CB16276834"><gtr:id>CC884DBE-E63D-416D-8328-48CB16276834</gtr:id><gtr:name>Manchester Royal Infirmary</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8FF77491-6D8F-46B3-A501-502C02F1142F"><gtr:id>8FF77491-6D8F-46B3-A501-502C02F1142F</gtr:id><gtr:name>Bristol Royal Infirmary</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DBCEE86-6873-4669-9B35-B4EEEAE13F52"><gtr:id>3DBCEE86-6873-4669-9B35-B4EEEAE13F52</gtr:id><gtr:name>Royal Liverpool University NHS Hospitals</gtr:name><gtr:address><gtr:line1>Prescot Street</gtr:line1><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L7 8XP</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46DB0EB7-3DE7-4E45-BFC0-2E7255E49A4B"><gtr:id>46DB0EB7-3DE7-4E45-BFC0-2E7255E49A4B</gtr:id><gtr:name>Bristol-Myers Squibb</gtr:name><gtr:address><gtr:line1>Bristol-Myers Squibb</gtr:line1><gtr:line2>311 Pennington Rocky Hill Road</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2CFA3CCE-D7B5-4E91-8299-47E773A16C97"><gtr:id>2CFA3CCE-D7B5-4E91-8299-47E773A16C97</gtr:id><gtr:name>Abbvie</gtr:name><gtr:address><gtr:line1>1 North Waukegan Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/14EB02E5-BEC0-4CCC-8EF4-CCECDD113817"><gtr:id>14EB02E5-BEC0-4CCC-8EF4-CCECDD113817</gtr:id><gtr:name>St George's NHS Trust, London</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/591A3A9A-B9DC-4D31-8660-2E747AAEDFAE"><gtr:id>591A3A9A-B9DC-4D31-8660-2E747AAEDFAE</gtr:id><gtr:name>Royal Sussex County Hospital</gtr:name><gtr:address><gtr:line1>Royal Sussex County Hospital</gtr:line1><gtr:line2>Eastern Road</gtr:line2><gtr:postCode>BN2  5BE</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CFA47428-36B9-43F1-A098-71C95C3D7474"><gtr:id>CFA47428-36B9-43F1-A098-71C95C3D7474</gtr:id><gtr:name>STOP-HCV</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E3676427-5C13-475A-8967-2EF6195347B5"><gtr:id>E3676427-5C13-475A-8967-2EF6195347B5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>McLauchlan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_EX_UU_G1000717"><gtr:id>59150B6F-4827-40AD-A663-1E058EB6C3BC</gtr:id><gtr:title>Establishment of a Resource for Long-Term Study of Hepatitis C Virus Infection in the UK - HCV Research UK</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MC_EX_UU_G1000717</gtr:grantReference><gtr:abstractText>Clinical problems associated with chronic infection by hepatitis C virus (HCV) will continue to increase in the UK for the foreseeable future. While there has been considerable progress with understanding the biology of the virus and improvements in healthcare provision, many issues relevant to the characteristics of HCV infection in the UK remain unresolved, such as the factors that contribute to development of serious liver disease and failure to respond to treatment. To address these issues, this proposal aims to create the infrastructure that will allow recruitment of a national cohort of at least 10,000 patients. Assembling a cohort of this size is necessary to generate a representative but sufficiently diverse collection of patient characteristics and clinical samples to explore in detail the determinants that may contribute to HCV pathogenesis and response to treatment. The key components of the national resource that will be created are a clinical research database for retaining details of patient characteristics, a biobank of clinical samples, which will form a UK repository, and a sequence and bioinformatics database to hold viral and host genetic information. The infrastructure will be supported by and build upon existing knowledge and expertise at national agencies (Health Protection Agency and Health Protection Scotland), the Gastroenterology and Liver Disease Biomedical Research Unit at Nottingham and the MRC Virology Unit in Glasgow. Patients will be recruited from clinical centres across most of the UK who provide care for HCV-infected patients. To provide proof of principle for the utility of clinical research and sequence databases combined with the availability of a biobank of clinical samples, a limited series of research projects will be performed. The projects will focus on examining whether there is a correlation between patient genetic markers and treatment outcome. In addition, the viral sequences of a large number of isolates for HCV genotypes 1 and 3 in different ethnic groups will be determined. These studies will provide the foundation for the information that will be deposited in the sequence and bioinformatics database. The availability of such a well-structured resource is highly likely to stimulate greater clinical and fundamental research into HCV infection in the UK and will also form the basis for longitudinal studies into the natural history of chronic infection in a large cohort of patients.</gtr:abstractText><gtr:technicalSummary>The healthcare burden associated with chronic hepatitis C virus (HCV) infection will continue to increase in the UK for the foreseeable future. While there has been considerable progress with understanding the biology of the virus and improvements in healthcare provision, many issues relevant to the characteristics of HCV infection in the UK remain unresolved, such as the host, viral, and environmental factors that contribute to development of serious liver disease and failure to respond to treatment. To address these issues, this proposal aims to: a) Establish a national cohort of 10,000 HCV-infected patients, supported by an integrated, standardised clinical database with demographic, clinical and laboratory parameters, b) Create a biobank of biological samples from the cohort for studies of host and viral factors associated with disease outcome and treatment response, c) Execute a limited set of research studies to generate viral and host sequence data to demonstrate the value and potential of the cohort and biobank, and d) Generate a bioinformatics database from the viral and host sequence data [acquired in c)], which can be linked to the clinical database [in a)]. Assembling a cohort of this size is necessary to generate a representative but sufficiently diverse collection of patient characteristics and clinical samples to explore in detail the determinants that may contribute to HCV pathogenesis and response to treatment. The infrastructure will be supported by and build upon existing knowledge and expertise at national agencies (Health Protection Agency and Health Protection Scotland), the Gastroenterology and Liver Disease Biomedical Research Unit at Nottingham and the MRC Virology Unit in Glasgow. Patients will be recruited from clinical centres across most of the UK who provide care for HCV-infected patients. To provide proof of principle for the utility of clinical research and sequence databases combined with the availability of a biobank of clinical samples, a limited series of research projects will be performed. The projects will focus on examining whether there is a correlation between single polynucleotide polymorphisms in host genomic sequences and treatment outcome. In addition, the viral sequences of a large number of isolates for HCV genotypes 1 and 3 in different ethnic groups will be determined. These studies will provide the foundation for the information that will be deposited in the sequence and bioinformatics database. The availability of such a well-structured resource is highly likely to stimulate greater clinical and fundamental research into HCV infection in the UK and will also form the basis for longitudinal studies into the natural history of chronic infection in a large cohort of patients.</gtr:technicalSummary><gtr:fund><gtr:end>2015-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bristol Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Bristol Royal Infirmary</gtr:description><gtr:id>77C5F4A1-A0E6-4A66-8474-96B83A057A60</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54638b3f43b6b3.62529358-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Preston Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Royal Preston</gtr:description><gtr:id>8A91B5A6-7920-4EB2-95FB-A745504C1C7E</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>546330820c2200.97282752-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>STOP-HCV</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>STOP-HCV</gtr:description><gtr:id>A81D6934-D161-445D-B603-EBE68A75BF5E</gtr:id><gtr:impact>Integrated studies on viral and host genetics.</gtr:impact><gtr:outcomeId>56dd5c9e4ab366.20193874-1</gtr:outcomeId><gtr:partnerContribution>Sharing of know-how and data on viral sequencing and host genotyping.</gtr:partnerContribution><gtr:piContribution>Provision of data and samples from HCV Research UK to STOP-HCV; sharing of know-how and data in viral sequeincing and host genotyping.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AbbVie</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>HCV Research UK - Abbvie</gtr:description><gtr:id>12B6A368-E0D6-4252-923B-77F2875DBF11</gtr:id><gtr:impact>Recruitment and data collectionfrom patients receiving new therapies for HCV infection.</gtr:impact><gtr:outcomeId>56dd58d5097252.70305305-1</gtr:outcomeId><gtr:partnerContribution>Provision of data from the HCV Research UK database</gtr:partnerContribution><gtr:piContribution>Provision of data from the HCV Research UK database</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St James's University Hospital (Jimmy's)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - St James, Leeds</gtr:description><gtr:id>3962E133-E737-4209-B535-5438785970CD</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5463280ca96e17.14619184-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>East Lancashire Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Royal Blackburn Hospital</gtr:department><gtr:description>HCV Research UK - Royal Blackburn Hospital</gtr:description><gtr:id>92AAC6B3-576F-4C07-ADB4-FA4728AAC686</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>546329963b9c38.12189333-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chelsea and Westminster Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Chelsea and Westminster, London</gtr:description><gtr:id>ADAA1ABE-91C0-46CC-8440-DEF704355F87</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54638c64a0e9e0.79908917-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bradford Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Bradford Royal Infirmary</gtr:description><gtr:id>91E156DC-F343-4FB2-BC98-9B53DBAA2CD4</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>546329156d4569.59537098-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Blackpool Victoria Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Blackpool Victoria Hospital</gtr:description><gtr:id>32CFAC8A-B6B5-4B8B-9DFB-9E553437804E</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54632a16cb9877.31585505-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hull Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Hull Royal Infirmary</gtr:description><gtr:id>C16A8A1B-DA01-4D65-B9DB-5BD94EBA346F</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54632c335c0732.04667863-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bristol-Myers Squibb</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HCV Research UK - Bristol Myers Squibb</gtr:description><gtr:id>AC7E9EF5-0DB5-44BA-8F13-4FB35F92AD33</gtr:id><gtr:impact>Presentation at EASL 2017 on outcomes from DAA Real World study.</gtr:impact><gtr:outcomeId>589ddd4971bd38.46421839-1</gtr:outcomeId><gtr:partnerContribution>Provision of data to BMS from HCV Research UK for a real world study on outcomes of use of DAAs for HCV-infected patients</gtr:partnerContribution><gtr:piContribution>Provision of data to BMS from HCV Research UK</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bradford Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Bradford Royal Infirmary</gtr:description><gtr:id>58DD7D64-0579-4C4C-B9DD-DDE70D93DB5D</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54632913e61c51.99290362-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>James Cook University Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - James Cook, Middlesborough</gtr:description><gtr:id>A49B286E-0F12-45E9-96E8-69800CFFD927</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5463289770c7a5.01747584-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Physics and Astronomy</gtr:department><gtr:description>HCV Research UK - Gilead and University of Nottingham</gtr:description><gtr:id>6335848A-09E7-4B93-8E22-D92879F426F7</gtr:id><gtr:impact>Presentation accepted for poster at International Liver meeting</gtr:impact><gtr:outcomeId>589dde0e73bb01.92839438-1</gtr:outcomeId><gtr:partnerContribution>Provision of data from HCV Research UK to University of Nottingham/Gilead for outcomes of use of DAAs for HCV-infected patients</gtr:partnerContribution><gtr:piContribution>Provision of data from HCV Research UK to University of Nottingham/Gilead.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johnson &amp; Johnson</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Janssen-Cilag</gtr:department><gtr:description>HCV Research UK - Janssen</gtr:description><gtr:id>98F8C1DC-DD2D-422B-98AA-218AFCBA9E79</gtr:id><gtr:impact>Data used for submission to NICE. Likely publication to arise.</gtr:impact><gtr:outcomeId>54629324a4f673.16262807-1</gtr:outcomeId><gtr:partnerContribution>HCV Research UK has provided data to Janssen following application to the Tissue and Data Access Committee. Selected data has been downloaded from the HCV Research UK database, quality controlled and then provided under an agreed contract.</gtr:partnerContribution><gtr:piContribution>Provision of data from HCV Research UK to Janssen for NICE submission</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Shrewsbury and Telford Hospital NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Royal Shrewsbury</gtr:description><gtr:id>127E1E65-A328-4212-94D1-1233ECDED12E</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54632ceeb0ad01.09340403-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Buckinghamshire Healthcare NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Wycombe</gtr:description><gtr:id>C0F48675-34BC-4F1A-A5C0-270450C9ADCD</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54632ae7ebb8e9.66843688-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boehringer Ingelheim</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>HCV Research UK - Boehringer Ingelheim</gtr:description><gtr:id>9616CD14-B49B-4F06-946F-9258E5A3AE41</gtr:id><gtr:impact>Data provided for ongoing support of HCV Research UK</gtr:impact><gtr:outcomeId>56dd5a8a2ae215.80258695-1</gtr:outcomeId><gtr:partnerContribution>Data provision form the HCV Research UK database</gtr:partnerContribution><gtr:piContribution>Data provision from the HCV Research UK database</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pennine Acute Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - North Manchester General Hospital</gtr:description><gtr:id>77C09E6D-1FFC-4E2C-97EE-D1FA0E69F3BC</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54633586ed90f2.66442745-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's NHS Trust, London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - St Georges, London</gtr:description><gtr:id>9571C914-C087-4FA5-950D-2F0D896F53A2</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54638ad9de44d5.39888399-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Portsmouth Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Queen Alexandra Hospital</gtr:department><gtr:description>HCV Research UK - Queen Alexandra Hospital, Portsmouth</gtr:description><gtr:id>E9E0091C-6478-44BD-8145-D135F02BD1A2</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54633026b1c5f2.24330148-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Liverpool University Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Royal Liverpool University Hospital</gtr:description><gtr:id>CCEA8791-BEA1-4D60-B521-EBAE93B2E6EE</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>546330fd6c9026.54193864-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Birmingham Heartlands Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Heartlands Hospital</gtr:description><gtr:id>8EAAF661-ED94-4FB7-A1A3-8E93FC2E910C</gtr:id><gtr:impact>N?A</gtr:impact><gtr:outcomeId>546325d3180672.11983828-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in the HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals of Morecambe Bay NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Royal Lancaster Infirmary</gtr:department><gtr:description>HCV Research UK - Royal Lancaster Infirmary</gtr:description><gtr:id>41623DCD-2768-43F0-8B19-5FB2ECB92DF8</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54632ddeea9253.46720403-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital Lewisham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - University Hospital Lewisham</gtr:description><gtr:id>C390D0D4-1A7E-4C0B-97C1-FA530191F1FE</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>546331a0f17ea5.62656511-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Sussex County Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Royal Sussex County Hospital, Brighton</gtr:description><gtr:id>53DFE5ED-0EB3-484D-B9B9-1FFF63D7F87E</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54638cd2c80490.50459723-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Gilead Sciences, Inc.</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HCV Research UK - Gilead</gtr:description><gtr:id>C4E63388-3CF7-4B82-B671-5F2A82FD75E9</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>589dde80e59b97.78001878-1</gtr:outcomeId><gtr:partnerContribution>Provision of data from HCV Research UK to Gilead</gtr:partnerContribution><gtr:piContribution>Provision of data from HCV Research UK to Gilead</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Manchester Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Manchester Royal Infirmary</gtr:description><gtr:id>850B021B-E103-454C-A0E3-3094ACCDAFE7</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54632f2b509e59.12948716-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Singleton Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Singleton Hospital, Swansea</gtr:description><gtr:id>0D199FD8-DD02-4A75-B4B1-09F8EB049067</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54638bded52fd9.46856017-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Southampton General Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Southampton General</gtr:description><gtr:id>F993F952-0AF0-4E08-AE96-A78E9E7590A4</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54632d5cf08d65.42433846-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Frimley Health NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HCV Research UK - Frimley Park</gtr:description><gtr:id>4D22CF66-264D-418B-B627-03CF5E168ABC</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>54638d2e105ca5.99040733-1</gtr:outcomeId><gtr:partnerContribution>Collection of HCV samples</gtr:partnerContribution><gtr:piContribution>Inclusion of HCV samples in HCV Research UK biobank</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>UK Clinical Pharmacists Association - Masterclass on HCV Treatment #2</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3517E58F-4622-4E36-95E8-20298CA89C13</gtr:id><gtr:impact>The workshop was aimed at clinical pharmacists to broaden their knowledge of new therapies for HCV infection and issues over drug resistance. Feedback from the event was that the presentation improved knowledge of new therapies and issues over their use.</gtr:impact><gtr:outcomeId>58c93206510f87.40983591</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Forum for HCV</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>81E92566-9177-48BB-ABB7-F61FD6B99B62</gtr:id><gtr:impact>Presented data on resistance identified in patients receiving new therapies for HCV infection to inform a national group about the possible importance of resistance testing.</gtr:impact><gtr:outcomeId>58c97544bdf2b9.08781303</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK  Clinical Pharmacists Association - Masterclass on HCV Treatment #1</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6BF237DE-64F8-42D8-A959-8BD71F0E3A5B</gtr:id><gtr:impact>The workshop was aimed at clinical pharmacists to broaden their knowledge of new therapies for HCV infection and issues over drug resistance. Feedback from the event was that the presentation improved knowledge of new therapies and issues over their use.</gtr:impact><gtr:outcomeId>58c931afa81218.55314914</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scottish Society for Gastroenterology</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4A91E2D1-78F0-4BDF-8B9C-4D7B4BD704D0</gtr:id><gtr:impact>Presented lecture on targets for new therapies for HCV infection and issues over drug resistance to clinicians at a national conference.</gtr:impact><gtr:outcomeId>58c9711d88c893.20610308</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Abbvie Medical Team</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC89F7A8-C860-41D3-9C94-4D7CAFC68800</gtr:id><gtr:impact>Organised an afternoon of speakers and presentations on a) HCV diagnostics now an din the future, b) sequencing methods for identifying resistance in patients who fail therapy and c) possible issues for difficult-to-treat patients with new therapies.</gtr:impact><gtr:outcomeId>58c974862e07e5.89186752</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2014,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sheila Sherlock Updates, Royal Free London</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A4DF161A-3574-4FEF-9910-FE1859E80AF9</gtr:id><gtr:impact>Presented invited lecture on targets for new therapies for HCV infection and issues over drug resistance to clinicians and academic staff.</gtr:impact><gtr:outcomeId>58c9345b035e94.91403591</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Carol Monaghan MP visit - 30 October 2015</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3EA22BEE-9ECB-4B3D-B4DD-E2278B0E2E8C</gtr:id><gtr:impact>Local MP of the Glasgow North West Constituency Carol Monaghan came to visit the CVR to meet with our Director Massimo Palmarini to learn about the important research carried out at the centre along with taking in a tour of the facility. Carol was able to meet with several of our researchers who provided short presentations about their research. Carol was very enthusiastic to learn about our research, links with industry and also about importance of funding. She then went on to mention the CVR and what she had learned during the visit at a parliamentary meeting in Westminster later that week. Furthermore, she then went on to visit one of the other Biomedical research centres that forms part of the University of Glasgow to gain a further insight into some of the important work and research being carried out across the University.</gtr:impact><gtr:outcomeId>56af5ece30d339.17399789</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>https://www.facebook.com/centreforvirusresearch/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NHS Research Scotland conference, QEUH, Glasgow</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C180B9B7-41B8-4F38-B829-BFC3B065270C</gtr:id><gtr:impact>Invited lecture on STOP-HCV and HCV Research UK to demonstrate benefits of stratified medicine for treating HCV infection.</gtr:impact><gtr:outcomeId>58c93546b2f835.17772796</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICGEB meeting on Human RNA Viruses, Costa Rica</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>856E28F9-4B7C-46CE-A110-36791820A8DF</gtr:id><gtr:impact>Gave invited lecture and allowed advertising the CVR as an international centre for virological research.</gtr:impact><gtr:outcomeId>58c971f3a85221.01832126</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.icgeb.org/rna-virus-workshop-2016.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Leicester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>54C3AF7B-B75B-4C63-BA35-0B694DAD0AA3</gtr:id><gtr:impact>Presentation on how different disciplines impact on virus research.</gtr:impact><gtr:outcomeId>58c970ca5cc064.57967965</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CVR Blog Post 2: Meet the Expert Dr John Mclachlan (Veronica Rezelj) - February 2015</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C6D058D9-EA38-48FF-8C63-EACADB72BAC7</gtr:id><gtr:impact>192 people read the blog post with likes reported on Facebook and Twitter.

The increased number of views versus the first post demonstrated a heightened awareness of the blog and therefore, demonstrated an uplift in followers.</gtr:impact><gtr:outcomeId>569788c798b1e0.40016076</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>https://www.facebook.com/centreforvirusresearch/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Biobank conference, Vienna, Austria</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CC0299C9-819A-4F56-96E4-EC3B180D8326</gtr:id><gtr:impact>Presented invited lecture on HCV Research UK to illustrate the sustainability of biobanks to an international audience.</gtr:impact><gtr:outcomeId>58c934cd429434.65206995</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HCV Research UK Press Release December 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>403736E6-3A97-41D6-868B-B95C147DF3F2</gtr:id><gtr:impact>In November of 2014, HCV Research UK, a consortium of experts in the field of Hepatitis C Virus who are leading a ground-breaking cohort study of Hepatitis C Virus infected patients, reached a landmark point in the project - recruiting 10,000 patients to the study ahead of their target date of the 31st December 2014. As a result of this success, we circulated a press release to the national press to share the news and also shared a story in the December edition of MRC Life.

The story featured in MRC Life, sharing this success story with other MRC Research Centres. The story was also features in the Viral Hepatitis in Practice publication in December 2014.</gtr:impact><gtr:outcomeId>552b7e08f0a356.98759018</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.gla.ac.uk/researchinstitutes/iii/cvr/news/headline_391453_en.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinical Staff - Invited Lecture on HCV Treatment</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5EEFA01A-D931-45C1-97D1-9FCAF4A58164</gtr:id><gtr:impact>Presented lecture on targets for new therapies for HCV infection and issues over drug resistance to clinicians and nursing staff. Feedback indicated that this improved knowledge of new treatments.</gtr:impact><gtr:outcomeId>58c932f89f2df1.08665769</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HCV Research UK Launch January 2013</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CB3FAF15-30BB-4CE9-BBF5-8283A63BBCEA</gtr:id><gtr:impact>HCV Research UK is a multi-disciplinary collaborative enterprise funded by a &amp;pound;1.92m grant from the Medical Research Foundation and based at the MRC-University of Glasgow Centre for Virus Research. 

This ground breaking initiative has involved the development of a Bio-repository of clinical samples and cohort study of greater than 10,000 patients infected by Hepatitis C Virus (HCV).

The database of information gathered about this cohort group is supporting the work of STOP-HCV and is also influencing prescribing decisions taken by the NHS. The information is also being made available for future research into HCV infection, thereby influencing and creating greater funding opportunities for research in this disease area.</gtr:impact><gtr:outcomeId>552682f8581f93.62519687</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://hcvresearchuk.org</gtr:url><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Showcase Event - HCV Research UK</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3FB9E055-1924-4B13-B676-1F1A1086C0F0</gtr:id><gtr:impact>The event was organised by the British Association for Study of the Liver/British Viral Hepatitis Groups to showcase consortia involved in HCV infection but primarily HCV Research UK. The purpose was to demonstrate the impact of HCV Research UK at the national level on collecting data and clinical samples to promote research into the virus, in particular with reference to the new therapies now available for treatment.</gtr:impact><gtr:outcomeId>58c9309c6ee560.08888275</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sun Yat-Sen University, Guangzhou, China</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>10B2F722-A629-4883-813A-F5FEBCB01AE4</gtr:id><gtr:impact>Invited lecture to promote collaboration between CVR and Sun Yat-Sen University. The outcome was a collaboration with the Guangzhou Blood Centre, which led to a 1 year working visit by a senior member of their staff to the CVR.</gtr:impact><gtr:outcomeId>58c933c31aca75.97068849</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Life - John McLachlan July 2015</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5E84739C-64F5-49C6-93F3-9F855222B327</gtr:id><gtr:impact>The article was posted on our Facebook and Twitter pages and encouraged online comments and likes.

No notable impact.</gtr:impact><gtr:outcomeId>569d07af802e69.27081528</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>https://www.facebook.com/centreforvirusresearch/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Abbvie #2</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>AbbVie</gtr:fundingOrg><gtr:id>551AA1CC-676E-48C8-82C7-AB39E15627A4</gtr:id><gtr:outcomeId>56dd891e5b7d19.94361581</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Gilead #5</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Gilead</gtr:fundingOrg><gtr:id>A624D56D-D833-4ADF-9F36-7897C6096A82</gtr:id><gtr:outcomeId>56dd87f716e1b7.47995719</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - BMS</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Bristol-Myers Squibb</gtr:fundingOrg><gtr:id>050BA624-FAA0-40BD-BACF-57011E0C90F3</gtr:id><gtr:outcomeId>54622af357bbd1.86557205</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>37500</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Janssen (Genotype 1 &amp;amp; 4)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Janssen Research &amp; Development</gtr:fundingOrg><gtr:id>B6EC125B-CE95-423F-89D4-C86384716A40</gtr:id><gtr:outcomeId>54622c2eb94f25.74665374</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - GSK</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>B9A97A5A-BC8B-4380-A623-67CD26D7284C</gtr:id><gtr:outcomeId>54622ab35a78b2.18613862</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>43000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Gilead #3</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Gilead</gtr:fundingOrg><gtr:id>2AD3D82C-402D-4E1F-891C-F73CBECD1391</gtr:id><gtr:outcomeId>56dd8733b3d8f4.85324655</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Gilead (triple therapy)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Gilead</gtr:fundingOrg><gtr:id>CC55C6AB-3D70-4790-AA3F-394732C9F85C</gtr:id><gtr:outcomeId>54622cff7a18f9.93433566</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15246</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - University of Liverpool</gtr:description><gtr:end>2020-05-02</gtr:end><gtr:fundingOrg>University of Liverpool</gtr:fundingOrg><gtr:fundingRef>C0365</gtr:fundingRef><gtr:id>63B1B2FA-24B6-494B-B5EF-8B00B307C6F0</gtr:id><gtr:outcomeId>58c83c037ceb45.26348290</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Gilead</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Gilead</gtr:fundingOrg><gtr:id>A1840182-7475-49F3-B44F-9C6819EA6335</gtr:id><gtr:outcomeId>54622b8d516f57.22697316</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2970</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - University of Plymouth</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>University of Plymouth</gtr:fundingOrg><gtr:fundingRef>C0365</gtr:fundingRef><gtr:id>9B32AF07-47DD-49C5-90ED-3745FEE5FABA</gtr:id><gtr:outcomeId>58c83c6d32aa19.02034950</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Janssen Diagnostics</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Janssen Research &amp; Development</gtr:fundingOrg><gtr:id>CE1B1682-81D8-4FEB-936B-EAFC2D97414E</gtr:id><gtr:outcomeId>54622c6bc0d559.38079493</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Gilead (NICE)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Gilead</gtr:fundingOrg><gtr:id>4C6821DC-3B99-4E3E-A9A4-89F83BCCC0EC</gtr:id><gtr:outcomeId>54622dceb10ec9.93806196</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Boehringer Ingelheim</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Boehringer Ingelheim</gtr:fundingOrg><gtr:id>9065565C-5184-47B7-8BE4-972F5E316611</gtr:id><gtr:outcomeId>54622b50eecc38.93207015</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>63000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - BMS#3</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Bristol-Myers Squibb</gtr:fundingOrg><gtr:id>477083E5-8BF2-4386-967D-F54A94EC8A36</gtr:id><gtr:outcomeId>56dd887cd06362.74272084</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - BMS#4</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Bristol-Myers Squibb</gtr:fundingOrg><gtr:id>0B81086A-703D-4D38-B813-DAE84C768B3D</gtr:id><gtr:outcomeId>56dd88d2dc55d5.47038371</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Gilead #6</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>Gilead Sciences, Inc.</gtr:fundingOrg><gtr:id>6311E6D4-B473-4045-BF23-24AFADCED4E0</gtr:id><gtr:outcomeId>58c83b702ed969.20387571</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Gilead #4</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Gilead</gtr:fundingOrg><gtr:id>E8136648-3E4A-475B-A072-BADC24E5B2B8</gtr:id><gtr:outcomeId>56dd879c5f33a6.77097991</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - BMS (EAP)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Bristol-Myers Squibb</gtr:fundingOrg><gtr:id>A99584F7-A279-4FB8-AC17-289748D8CD26</gtr:id><gtr:outcomeId>54622e82c72838.43403501</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Janssen</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Janssen Research &amp; Development</gtr:fundingOrg><gtr:id>1039E504-3794-4165-A987-1EF056D09AAB</gtr:id><gtr:outcomeId>54622bd9f0d5d6.52522338</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Gilead (EAP)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Gilead</gtr:fundingOrg><gtr:id>C0699374-5B4D-4BC9-A8E1-12DEBA4999FC</gtr:id><gtr:outcomeId>54622e512d63f1.01271159</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Abbvie #1</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>AbbVie</gtr:fundingOrg><gtr:id>0DA71FE2-06FA-43A1-BB4E-A5484E4123A1</gtr:id><gtr:outcomeId>56dd60b512e5d0.00393614</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - STOP-HCV</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F400F3D4-1E66-458F-97A4-58F3B9DB7357</gtr:id><gtr:outcomeId>54622cc074ac46.65456226</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - Glasgow Caledonian University</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>Glasgow Caledonian University (GCU)</gtr:fundingOrg><gtr:fundingRef>C0365</gtr:fundingRef><gtr:id>B9BDEB37-26E0-49D0-9F0E-3DD69860AE67</gtr:id><gtr:outcomeId>58c92ce6761a92.24741051</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HCV Research UK - BMS #2</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Bristol-Myers Squibb</gtr:fundingOrg><gtr:id>67F52441-34AA-498F-BAC0-90E9A032A4AF</gtr:id><gtr:outcomeId>54622d9f2c3f16.75010783</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>HCV Research UK holds the clinical data for approximately 11,000 patients infected with hepatitis C virus in the UK. We also have a linked biobank database for holding the information on all samples processed and stored in the HCV Research UK biorepository.</gtr:description><gtr:id>04C02F0C-DE57-4BC8-81EC-020160521662</gtr:id><gtr:impact>The data and samples have been used for a number of purposes including:
1. Submissions to NICE by pharma companies
2. Submission to the European Medicines Agency on drug utilisation
3. Data provided, in combination with samples, for extensive viral sequencing and host genetic studies.
4. Acting as the data and sample repository for a Gilead-funded phase III clinical trial in the UK, USA and Australia (BOSON)
5 Acting as the data and sample repository for the NHS England Early Access Programme that provides IFN-free, all oral therapy to HCV-infected patients with serious liver disease.
6. Underpins the data and samples provided to the STOP-HCV MRC-funded consortium.
7. Provides infrastructure support for the STOP-HCV Cirrhosis study and the STOP-HCV1 EME study.</gtr:impact><gtr:outcomeId>545a650aef5af9.19711423</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HCV Research UK</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.hcvresearchuk.org</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Information from consenting patients have been entered into a clinical database. These patients also provide clinical samples for the biobank. The clinical database and management system for the biobank are bespoke systems built specifically for HCV Research UK. They have been developed such that interaction between the two database systems can be achieved. The data and samples are made available to researchers (either in academia or the pharmaceutical industry; both UK- and non-UK-based)</gtr:description><gtr:id>B70D85FF-3155-4EAA-9B1A-36149C29566C</gtr:id><gtr:impact>The establishment of HCV Research UK has underpinned and directly enabled the following:
1. Award of &amp;pound;4M grant on MRC call for Stratified Medicine to the STOP-HCV consortium, a group of academic institutions, national health agencies and pharmaceutical companies.
2. Requests from several pharmaceutical companies for access to data for submissions to NICE for new anti-viral compounds.
3. Requests from pharmaceutical companies for access to samples for new diagnostic tests.
4. Access to data and samples from HCV-infected patients from across the UK for phyloepidemiological studies.
5. Provided a large number of samples for development of high throughput sequencing methodologies.
6. Provided the samples for a Health Innovation Challenge Fund award by Wellcome Trust for enabling roll-out of high throughput sequencing across NHS sites.
7. Enabled collection of data and samples on Early Access Programme, an initiative funded by NHS England to allow patients access to interferon-free therapies for HCV infection ahead of NICE approval.</gtr:impact><gtr:outcomeId>JgpXTGZ3aGN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HCV Research UK Clinical Database and Biobank</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.hcvresearchuk.org/</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The technology enabled the enrichment of HCV-specific sequences in Next Generation Sequencing. It also increased the numbers of samples that could be included in a single sequencing run from about 10-12 to 90, which is much more cost effective.</gtr:description><gtr:id>938F80B2-8675-4DFF-96B3-66A7DE50E2D7</gtr:id><gtr:impact>The methodology is now being developed for diagnostic services and to establish an enrichment platform for flaviviruses circulating in the Philippines.</gtr:impact><gtr:outcomeId>58c979a36cc9f2.13374236</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>NGS Target Enrichment</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>53279A58-EF1A-4D98-AD3C-B9A89D03AC74</gtr:id><gtr:title>Comparison of Next-Generation Sequencing Technologies for Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f184e1a5169e970ee2668a72321eb0c"><gtr:id>2f184e1a5169e970ee2668a72321eb0c</gtr:id><gtr:otherNames>Thomson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>588b612f2608f2.46199024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>130A63B6-E7E4-483B-9EE7-B2D52B3FC428</gtr:id><gtr:title>Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa56070c948c0fb966fe86c46b8bd5f7"><gtr:id>aa56070c948c0fb966fe86c46b8bd5f7</gtr:id><gtr:otherNames>Foster GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>56dd53f425e378.14003971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58D81386-1BE2-4A6D-917E-5940D6D1D981</gtr:id><gtr:title>Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/640066d44c0c0ff681f127fcc480dff3"><gtr:id>640066d44c0c0ff681f127fcc480dff3</gtr:id><gtr:otherNames>Cheung MCM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>589ddb07398eb2.25251183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EA66E7F-5681-4884-A902-C99376C2A4C8</gtr:id><gtr:title>Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cc1a629d431ece4a70f4e2339867e5a"><gtr:id>4cc1a629d431ece4a70f4e2339867e5a</gtr:id><gtr:otherNames>da Silva Filipe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>5a661667d25df5.16928953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEB6A488-CDC8-42B3-B15A-CBAD0006CDC3</gtr:id><gtr:title>Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries</gtr:title><gtr:parentPublicationTitle>JOURNAL OF HEPATOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa2971e0e0517f675e1dbcc45b7c3eb2"><gtr:id>fa2971e0e0517f675e1dbcc45b7c3eb2</gtr:id><gtr:otherNames>Filipe Ana da Silva</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>5a34ec6054d3e7.39622038</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60F2AEF1-5057-43E9-AFF4-B5B48D1E0FB7</gtr:id><gtr:title>Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a8c3bb19afe31ed1202a22f36057dcc"><gtr:id>6a8c3bb19afe31ed1202a22f36057dcc</gtr:id><gtr:otherNames>McLauchlan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>5a34ec6dd2caa7.41692734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7F5D07F-DDE0-4029-8B4D-92D64602AC42</gtr:id><gtr:title>Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f910cfd938f25e6e6e45c466f2c7dc1"><gtr:id>1f910cfd938f25e6e6e45c466f2c7dc1</gtr:id><gtr:otherNames>Ansari MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a34ec8c8e21e3.70856101</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_EX_UU_G1000717</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>